Estrella Immunopharma, Inc. ESLA

0.48 0.01 2.13% as of 25 Sep

Follow ESLA

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	148.05%	373.21%	255.59%	199.78%	+8 more TTM periods Free account
ROA Full definition →	(416.74%)	(434.36%)	(413.55%)	(250.19%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	134.74%	195.73%	110.09%	80.10%
Free Cash Flow per Share Full definition →	(0.22)	(0.19)	(0.05)	0.05
Free Cash Flow Full definition →	(9.38)	(8.02)	(1.79)	2.02
Piotroski F-Score Full definition →	2.00	2.00	1.00	2.00
Other line items
Cash ROIC Full definition →	128.81%	239.84%	19.88%	(24.63%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	0.94	0.61	0.14	(0.22)
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.22)	(0.19)	(0.05)	0.05
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Net Profit Margin Full definition →	0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack